Astera Labs Stock Rises 10.1% to $142.57
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Apr 10 2026
0mins
Should l Buy ALAB?
Astera Labs is up 10.1%, or $13.11 to $142.57.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ALAB?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on ALAB
Wall Street analysts forecast ALAB stock price to rise
19 Analyst Rating
14 Buy
5 Hold
0 Sell
Moderate Buy
Current: 174.050
Low
155.00
Averages
206.18
High
250.00
Current: 174.050
Low
155.00
Averages
206.18
High
250.00
About ALAB
Astera Labs, Inc. is a global semiconductor company. The Company provides semiconductor-based connectivity solutions for cloud and artificial intelligence (AI) infrastructure. It has developed and deployed its Intelligent Connectivity Platform built from the ground up for cloud and AI infrastructure. Its Intelligent Connectivity Platform provides its customers with the ability to deploy and operate high-performance cloud and AI infrastructure at scale, addressing an increasingly diverse set of requirements. It provides its connectivity products in various form factors, including Integrated Circuits (ICs), boards, and modules. Its PCIe, CXL and Ethernet semiconductor-based connectivity solutions are purpose-built to unleash the potential of accelerated computing at cloud-scale. The Company’s products include Aries products, which include its COSMOS software suite; Taurus products, which are hardware modules based on its Taurus ICs; Leo products; and Scorpio products.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
ASTERA LABS, INC: RBC Increases Target Price from $225 to $250
- Company Announcement: Aster Labs, Inc. has raised its price target for RBC to $250, up from a previous target of $225.
- Market Impact: This adjustment reflects a positive outlook on RBC's performance and potential growth in the market.
See More
Astera Labs (ALAB.US) Insider Plans to Sell $4.37 Million in Common Stock via Form 144
Stock Sale Announcement: Aster Labs plans to sell 24,998 shares of its common stock on April 17.
Market Value: The total market value of the shares being sold is approximately $4.37 million.
See More
Astera Labs (ALAB.US) Insider Plans to Sell $70.46 Million in Common Stock via Form 144
Share Sale Announcement: Jitendra Mohan intends to sell 412.5K shares of Astera Labs on April 17, with a total market value of approximately $70.46 million.
Reduction in Holdings: Since February 17, 2026, Jitendra Mohan has reduced his shareholding in Astera Labs by 379.19K shares, valued at around $51.52 million.
See More
Astera Labs (ALAB.US) Insider Plans to Sell $35.19 Million in Common Stock via Form 144
Stock Sale Announcement: Jitendra Mohan plans to sell 206.25K shares of Astera Labs on April 15, with a total market value of approximately $35.19 million.
Reduction in Holdings: Since February 17, 2026, Jitendra Mohan has reduced his shareholding in Astera Labs by 376.22K shares, valued at around $51 million.
See More
Astera Labs Shares Surge 27.2% Amid Strong Earnings Expectations
- Stock Surge: Astera Labs' share price surged by 27.2% week-over-week, reflecting investor confidence in the company's anticipated strong first-quarter earnings, indicating robust market sentiment.
- Optimistic Financial Outlook: The company expects first-quarter revenues to grow by 78% to 86% year-over-year, reaching between $286 million and $297 million, significantly up from $159.4 million in the same period last year, showcasing strong market demand.
- Doubling EPS Expectations: GAAP diluted earnings per share are projected to at least double to a range of $0.36 to $0.38, compared to $0.18 in the same quarter last year, highlighting a substantial enhancement in the company's profitability.
- R&D Center Expansion: Astera Labs plans to establish an advanced R&D center in Israel to accelerate the development of next-generation high-bandwidth connectivity protocols while addressing memory bottlenecks in AI training and inference applications, further solidifying its leadership in technological innovation.
See More
Global X Cybersecurity ETF Underperforms
- ETF Decline: The Global X Cybersecurity ETF (BUG) fell approximately 4.9% during Friday afternoon trading, reflecting market concerns about the cybersecurity sector, which could impact investor confidence and lead to capital outflows.
- Weak Individual Stocks: Within the ETF, shares of Akamai Technologies (AKAM) dropped about 11.2%, while Palo Alto Networks (PANW) fell approximately 9%, indicating a weakening market outlook for these companies that may affect their ability to raise funds.
- Market Reaction Analysis: This decline may be linked to overall market sentiment, as investors adopt a cautious stance towards the cybersecurity industry's prospects, potentially putting more pressure on related firms in the short term.
- Investor Focus: Despite the ETF's poor performance, investors should remain attentive to technological innovations and shifts in market demand within the cybersecurity sector, as these factors could present potential investment opportunities in the long run.
See More
ASTERA LABS, INC: RBC Increases Target Price from $225 to $250
- Company Announcement: Aster Labs, Inc. has raised its price target for RBC to $250, up from a previous target of $225.
- Market Impact: This adjustment reflects a positive outlook on RBC's performance and potential growth in the market.
See More
Astera Labs (ALAB.US) Insider Plans to Sell $4.37 Million in Common Stock via Form 144
Stock Sale Announcement: Aster Labs plans to sell 24,998 shares of its common stock on April 17.
Market Value: The total market value of the shares being sold is approximately $4.37 million.
See More
Astera Labs (ALAB.US) Insider Plans to Sell $70.46 Million in Common Stock via Form 144
Share Sale Announcement: Jitendra Mohan intends to sell 412.5K shares of Astera Labs on April 17, with a total market value of approximately $70.46 million.
Reduction in Holdings: Since February 17, 2026, Jitendra Mohan has reduced his shareholding in Astera Labs by 379.19K shares, valued at around $51.52 million.
See More
Astera Labs (ALAB.US) Insider Plans to Sell $35.19 Million in Common Stock via Form 144
Stock Sale Announcement: Jitendra Mohan plans to sell 206.25K shares of Astera Labs on April 15, with a total market value of approximately $35.19 million.
Reduction in Holdings: Since February 17, 2026, Jitendra Mohan has reduced his shareholding in Astera Labs by 376.22K shares, valued at around $51 million.
See More
Astera Labs Shares Surge 27.2% Amid Strong Earnings Expectations
- Stock Surge: Astera Labs' share price surged by 27.2% week-over-week, reflecting investor confidence in the company's anticipated strong first-quarter earnings, indicating robust market sentiment.
- Optimistic Financial Outlook: The company expects first-quarter revenues to grow by 78% to 86% year-over-year, reaching between $286 million and $297 million, significantly up from $159.4 million in the same period last year, showcasing strong market demand.
- Doubling EPS Expectations: GAAP diluted earnings per share are projected to at least double to a range of $0.36 to $0.38, compared to $0.18 in the same quarter last year, highlighting a substantial enhancement in the company's profitability.
- R&D Center Expansion: Astera Labs plans to establish an advanced R&D center in Israel to accelerate the development of next-generation high-bandwidth connectivity protocols while addressing memory bottlenecks in AI training and inference applications, further solidifying its leadership in technological innovation.
See More
Global X Cybersecurity ETF Underperforms
- ETF Decline: The Global X Cybersecurity ETF (BUG) fell approximately 4.9% during Friday afternoon trading, reflecting market concerns about the cybersecurity sector, which could impact investor confidence and lead to capital outflows.
- Weak Individual Stocks: Within the ETF, shares of Akamai Technologies (AKAM) dropped about 11.2%, while Palo Alto Networks (PANW) fell approximately 9%, indicating a weakening market outlook for these companies that may affect their ability to raise funds.
- Market Reaction Analysis: This decline may be linked to overall market sentiment, as investors adopt a cautious stance towards the cybersecurity industry's prospects, potentially putting more pressure on related firms in the short term.
- Investor Focus: Despite the ETF's poor performance, investors should remain attentive to technological innovations and shifts in market demand within the cybersecurity sector, as these factors could present potential investment opportunities in the long run.
See More
